array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(26) "Natus Medical Incorporated"
["slug"]=>
string(35) "05e48-us-natus-medical-incorporated"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/a15c3f67-a529-4950-a831-d87d6d0fff2a"
["description"]=>
string(897) "Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status."
["address_street"]=>
string(29) "6701 Koll Center Pkwy Ste 120"
["address_place"]=>
string(10) "Pleasanton"
["address_region"]=>
string(10) "California"
["founding_date"]=>
string(10) "1987-02-13"
["website_domain"]=>
string(9) "natus.com"
["website_url"]=>
string(17) "https://natus.com"
["industry_codes"]=>
array(1) {
[0]=>
string(47) "Electromedical and Electrotherapeutic Apparatus"
}
["employee_count"]=>
int(1480)
["article_count"]=>
int(148)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(75) "Natus Medical (NASDAQ:NTUS) Coverage Initiated by Analysts at StockNews.com"
["snippet_en"]=>
string(181) "StockNews.com began coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report report published on Friday. The brokerage issued a buy rating on the stock."
["url"]=>
string(110) "https://reporter.am/2022/10/08/natus-medical-nasdaqntus-coverage-initiated-by-analysts-at-stocknews-com-3.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/be786626-c4f0-4573-9b45-eec5faa2723f"
["source"]=>
string(11) "reporter.am"
["publication_date"]=>
string(10) "2022-10-08"
["categories"]=>
array(3) {
[0]=>
string(12) "Stock Market"
[1]=>
string(13) "Credit Rating"
[2]=>
string(10) "Litigation"
}
}
[1]=>
array(7) {
["title_en"]=>
string(65) "Natus Medical (NASDAQ:NTUS) is currently covered by StockNews.com"
["snippet_en"]=>
string(193) "Stock analysts at StockNews.com started coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock."
["url"]=>
string(89) "https://reporter.am/2022/10/01/natus-medical-nasdaqntus-now-covered-by-stocknews-com.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a12680e7-4586-4c98-8bf2-751ad0dcfc81"
["source"]=>
string(11) "reporter.am"
["publication_date"]=>
string(10) "2022-10-01"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(13) "Credit Rating"
[3]=>
string(10) "Litigation"
}
}
[2]=>
array(7) {
["title_en"]=>
string(75) "Natus Medical (NASDAQ:NTUS) Coverage Initiated by Analysts at StockNews.com"
["snippet_en"]=>
string(197) "StockNews.com initiated coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report sent to investors on Wednesday morning. The brokerage issued a buy rating on the stock."
["url"]=>
string(108) "https://reporter.am/2022/09/22/natus-medical-nasdaqntus-coverage-initiated-by-analysts-at-stocknews-com.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/e16b7f9f-79b4-4046-b1c1-05aea17b9efb"
["source"]=>
string(11) "reporter.am"
["publication_date"]=>
string(10) "2022-09-22"
["categories"]=>
array(4) {
[0]=>
string(12) "Stock Market"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(13) "Credit Rating"
[3]=>
string(10) "Litigation"
}
}
[3]=>
array(7) {
["title_en"]=>
string(68) "Natus Medical beats the Street in Q4, announces business realignment"
["snippet_en"]=>
string(113) "Natus Medical (NSDQ:NTUS) this week posted fourth-quarter results that beat the overall consensus on Wall Street."
["url"]=>
string(100) "https://www.massdevice.com/natus-medical-beats-the-street-in-q4-announces-realignment-of-businesses/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/7758b49e-2584-4b29-9d16-89bc52982dc7"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2022-02-25"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[4]=>
array(7) {
["title_en"]=>
string(75) "Natus Medical Announces Fourth Quarter and Full Year 2019 Financial Results"
["snippet_en"]=>
string(151) "Fourth quarter revenue of $131.8 millionFourth quarter GAAP earnings per diluted share of $0.10Fourth quarter non-GAAP earnings per diluted share of..."
["url"]=>
string(147) "https://www.globenewswire.com/news-release/2020/02/06/1981422/0/en/Natus-Medical-Announces-Fourth-Quarter-and-Full-Year-2019-Financial-Results.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/25f82ef5-5b10-4a4a-851b-a86590424817"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2020-02-06"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[5]=>
array(7) {
["title_en"]=>
string(40) "Natus Medical gains on Q3 swing to black"
["snippet_en"]=>
string(181) "Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street."
["url"]=>
string(68) "https://www.massdevice.com/natus-medical-gains-on-q3-swing-to-black/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c929e762-681b-4907-b741-2e5069c8de64"
["source"]=>
string(14) "massdevice.com"
["publication_date"]=>
string(10) "2019-10-28"
["categories"]=>
array(3) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(12) "Stock Market"
[2]=>
string(31) "Financial Update/Profit Warning"
}
}
[6]=>
array(7) {
["title_en"]=>
string(38) "Natus Announces Sale of Medix Business"
["snippet_en"]=>
string(76) "“Local Management to acquire the stock of Natus' Argentinian subsidiary”"
["url"]=>
string(110) "https://www.globenewswire.com/news-release/2019/04/02/1795764/0/en/Natus-Announces-Sale-of-Medix-Business.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f72d4cf4-eeff-4258-b1ff-688f7164a937"
["source"]=>
string(17) "globenewswire.com"
["publication_date"]=>
string(10) "2019-04-02"
["categories"]=>
array(3) {
[0]=>
string(10) "Divestment"
[1]=>
string(12) "Stock Market"
[2]=>
string(11) "Acquisition"
}
}
[7]=>
array(7) {
["title_en"]=>
string(49) "Natus Medical Inc. Fell 11% in April. Here's Why."
["snippet_en"]=>
string(84) "A bottom-line contraction in the first quarter isn't what the market wanted to hear."
["url"]=>
string(76) "https://foxbusiness.com/markets/natus-medical-inc-fell-11-in-april-heres-why"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0d3af3fb-b020-4fda-bfa4-94ead1a125e3"
["source"]=>
string(15) "foxbusiness.com"
["publication_date"]=>
string(10) "2017-05-08"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[8]=>
array(7) {
["title_en"]=>
string(61) "Why Halliburton, GNC Holdings, and Natus Medical Jumped Today"
["snippet_en"]=>
string(57) "These stocks helped lead the market higher. Find out why."
["url"]=>
string(95) "https://www.foxbusiness.com/markets/why-halliburton-gnc-holdings-and-natus-medical-jumped-today"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/f94f6c9f-24f4-4e6d-8639-3c812413e3b2"
["source"]=>
string(15) "foxbusiness.com"
["publication_date"]=>
string(10) "2016-10-19"
["categories"]=>
array(2) {
[0]=>
string(12) "Stock Market"
[1]=>
string(15) "Market Movement"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(23)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(12)
}
[2]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(11)
}
[3]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[4]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(5)
}
[6]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(4)
}
[7]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(4)
}
[8]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(4)
}
[9]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(3)
}
[10]=>
array(2) {
["name"]=>
string(5) "SPACs"
["count"]=>
int(3)
}
[11]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(3)
}
[12]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(3)
}
[13]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(3)
}
[14]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(2)
}
[15]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(2)
}
[16]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[17]=>
array(2) {
["name"]=>
string(10) "Downsizing"
["count"]=>
int(2)
}
[18]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(2)
}
[19]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(2)
}
[20]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(2)
}
[21]=>
array(2) {
["name"]=>
string(22) "Shareholder Reputation"
["count"]=>
int(2)
}
[22]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(2)
}
[23]=>
array(2) {
["name"]=>
string(5) "Fraud"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(19) "Investment Requests"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(5) "Debts"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(10) "Complaints"
["count"]=>
int(1)
}
}
}
05e48-us-natus-medical-incorporated
Natus Medical Incorporated
Location
California
Founded
1987-02-13
Website
https://natus.com
Articles
148 Articles
Category
Electromedical and Electrotherapeutic Apparatus
Description
Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems.
Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories around the world.
Natus does not endorse personal/non-work related comments made by employees on social media. Further, Natus values the respect and inclusion of all people without regard to race, color, religion, sex, national origin, veteran status, disability, sexual orientation, gender identity, or any other protected status.
StockNews.com began coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report report published on Friday. The brokerage issued a buy rating on the stock.
Stock analysts at StockNews.com started coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a note issued to investors on Thursday. The firm set a “buy” rating on the stock.
StockNews.com initiated coverage on shares of Natus Medical (NASDAQ:NTUS – Get Rating) in a research report sent to investors on Wednesday morning. The brokerage issued a buy rating on the stock.
Natus Medical (NSDQ:NTUS) swung from red to black with its third-quarter results and raised its earnings outlook for the rest of the year, sending its share price up on Wall Street.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
